Jane Street Group, LLC Omega Therapeutics, Inc. Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.86 - $3.2 $397,104 - $683,190	213,497 New	213,497 $441,000
Q4 2023 Feb 14, 2024	BUY	$1.35 - $3.21 $42,202 - $100,347	31,261 New	31,261 $94,000
Q1 2023 May 15, 2023	BUY	$4.81 - $10.95 $443,217 - $1.01 Million	92,145 New	92,145 $555,000
Q1 2022 May 17, 2022	SELL	$6.24 - $14.04 $111,864 - $251,695	-17,927 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$11.33 - $29.38 $203,112 - $526,695	17,927 New	17,927 $203,000

43.4M

25.8K

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $23.4M
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.